Dyspnea — The Relating Experienced To Recalled Breathlessness Observational Study
Citation(s)
Bowden JA, To TH, Abernethy AP, Currow DC Predictors of chronic breathlessness: a large population study. BMC Public Health. 2011 Jan 12;11:33. doi: 10.1186/1471-2458-11-33.
Mead J Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis. 1980 Feb;121(2):339-42.
Meek PM, Lareau SC, Anderson D Memory for symptoms in COPD patients: how accurate are their reports? Eur Respir J. 2001 Sep;18(3):474-81.
Miravitlles M, Ferrer J, Baró E, Lleonart M, Galera J Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med. 2013 Dec;107(12):1977-85. doi: 10.1016/j.rmed.2013.06.019. Epub 2013 Jul 24.
Walentynowicz M, Bogaerts K, Van Diest I, Raes F, Van den Bergh O Was it so bad? The role of retrospective memory in symptom reporting. Health Psychol. 2015 Dec;34(12):1166-74. doi: 10.1037/hea0000222. Epub 2015 May 25. Erratum in: Health Psychol. 2015 Dec;34(12):1184.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
